Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-01-09 Sale |
2023-01-10 8:07 pm |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
12,000 | $46.08 | $552,960 | 1,167,774 (Direct) |
View |
2023-01-05 Sale |
2023-01-09 7:02 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico Chief Medical Officer |
2,500 | $48.79 | $121,975 | 94,884 (Direct) |
View |
2023-01-03 Sale |
2023-01-05 8:00 pm |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
5,000 | $50.7 | $253,500 | 345,407 (Direct) |
View |
2023-01-03 Sale |
2023-01-05 7:40 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
500 | $50.7 | $25,350 | 405,331 (Indirect Direct) |
View |
2022-12-19 Sale |
2022-12-21 4:13 pm |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
28,200 | $52.06 | $1,467,983 | 2,494,191 (Indirect Direct) |
View |
2022-12-15 Sale |
2022-12-19 4:37 pm |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $52.35 | $65,438 | 789,253 (Indirect Direct) |
View |
2022-12-08 Sale |
2022-12-12 4:28 pm |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
12,000 | $47.5 | $570,000 | 1,172,774 (Direct) |
View |
2022-12-05 Sale |
2022-12-07 08:30 am |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
5,000 | $50.38 | $251,900 | 350,407 (Direct) |
View |
2022-12-01 Sale |
2022-12-02 4:30 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
500 | $49.93 | $24,965 | 401,964 (Indirect Direct) |
View |
2022-12-01 Sale |
2022-12-02 4:30 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico Chief Medical Officer |
2,500 | $49.93 | $124,825 | 97,384 (Direct) |
View |
2022-11-15 Sale |
2022-11-17 4:33 pm |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $48.01 | $60,013 | 790,503 (Indirect Direct) |
View |
2022-11-08 Sale |
2022-11-10 08:30 am |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
12,000 | $46.47 | $557,640 | 1,184,774 (Direct) |
View |
2022-11-03 Sale |
2022-11-07 4:19 pm |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
5,000 | $58.54 | $292,700 | 355,407 (Direct) |
View |
2022-11-01 Sale |
2022-11-03 4:28 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
500 | $60.83 | $30,415 | 402,464 (Indirect Direct) |
View |
2022-11-01 Sale |
2022-11-03 4:27 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico Chief Medical Officer |
2,500 | $60.83 | $152,075 | 99,884 (Direct) |
View |
2022-10-14 Sale |
2022-10-17 5:57 pm |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $59.31 | $74,138 | 791,753 (Indirect Direct) |
View |
2022-10-10 Sale |
2022-10-11 4:58 pm |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
12,000 | $57.5 | $690,000 | 1,196,774 (Direct) |
View |
2022-10-03 Sale |
2022-10-05 5:14 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
2,500 | $66.69 | $166,725 | 102,384 (Direct) |
View |
2022-10-03 Sale |
2022-10-05 5:12 pm |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
5,000 | $66.69 | $333,450 | 360,407 (Direct) |
View |
2022-09-15 Sale |
2022-09-16 4:03 pm |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $66 | $82,500 | 793,003 (Indirect Direct) |
View |
2022-09-08 Sale |
2022-09-12 4:52 pm |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
12,000 | $63.98 | $767,760 | 1,208,774 (Direct) |
View |
2022-09-08 Sale |
2022-09-08 4:38 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
15,000 | $65 | $975,000 | 402,964 (Indirect Direct) |
View |
2022-09-06 Sale |
2022-09-07 4:37 pm |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
5,000 | $60.38 | $301,900 | 365,407 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-01-12 Option Award |
2023-01-17 7:35 pm |
N/A 2033-01-11 |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
35,472 | $52.66 | 89,702 (Direct) |
View |
2023-01-12 Option Award |
2023-01-17 7:35 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
22,580 | $0 | 89,702 (Direct) |
View |
2023-01-12 Option Award |
2023-01-17 7:33 pm |
N/A 2033-01-11 |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
30,845 | $52.66 | 1,034,259 (Direct) |
View |
2023-01-12 Option Award |
2023-01-17 7:33 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
19,634 | $0 | 1,034,259 (Direct) |
View |
2023-01-12 Option Award |
2023-01-17 7:28 pm |
N/A 2033-01-11 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
30,845 | $52.66 | 79,533 (Direct) |
View |
2023-01-12 Option Award |
2023-01-17 7:28 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
19,634 | $0 | 79,533 (Direct) |
View |
2023-01-12 Option Award |
2023-01-17 7:26 pm |
N/A 2033-01-11 |
Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer |
15,114 | $52.66 | 43,186 (Direct) |
View |
2023-01-12 Option Award |
2023-01-17 7:26 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer |
9,621 | $0 | 43,186 (Direct) |
View |
2023-01-09 Exercise |
2023-01-10 8:07 pm |
N/A 2023-12-05 |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
18,500 | $0 | 1,167,774 (Direct) |
View |
2023-01-09 Exercise |
2023-01-10 8:07 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
18,500 | $2.67 | 1,167,774 (Direct) |
View |
Ownership |
2023-01-09 4:44 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Baumal Caroline Chief Medical Officer |
0 | $0 | 133 (Direct) |
View |
2023-01-03 Exercise |
2023-01-05 8:00 pm |
N/A 2028-11-15 |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
5,000 | $0 | 345,407 (Direct) |
View |
2023-01-03 Exercise |
2023-01-05 8:00 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
5,000 | $15.09 | 345,407 (Direct) |
View |
2023-01-03 Option Award |
2023-01-05 7:57 pm |
N/A 2033-01-02 |
Apellis Pharmaceuticals Inc. | APLS | Baumal Caroline Chief Medical Officer |
49,000 | $50.28 | 84,682 (Direct) |
View |
2023-01-03 Option Award |
2023-01-05 7:57 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Baumal Caroline Chief Medical Officer |
35,549 | $0 | 84,682 (Direct) |
View |
Ownership |
2023-01-05 7:48 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Baumal Caroline Chief Medical Officer |
0 | $0 | 133 (Direct) |
View |
2023-01-01 Option Award |
2023-01-04 5:37 pm |
N/A 2030-12-31 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
11,308 | $0 | 687,032 (Direct) |
View |
2023-01-01 Option Award |
2023-01-04 5:35 pm |
N/A 2030-12-31 |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
11,308 | $0 | 413,272 (Direct) |
View |
2023-01-01 Option Award |
2023-01-04 5:33 pm |
N/A 2030-12-31 |
Apellis Pharmaceuticals Inc. | APLS | O'Brien Stephanie Monaghan Director |
11,308 | $0 | 15,538 (Direct) |
View |
2023-01-01 Option Award |
2023-01-04 5:33 pm |
N/A 2030-12-31 |
Apellis Pharmaceuticals Inc. | APLS | Chan Gerald Director |
11,308 | $0 | 15,538 (Direct) |
View |
2023-01-01 Option Award |
2023-01-04 5:31 pm |
N/A 2030-12-31 |
Apellis Pharmaceuticals Inc. | APLS | FONTEYNE PAUL R. Director |
11,308 | $0 | 20,538 (Direct) |
View |
2022-12-29 Exercise |
2022-12-30 5:00 pm |
N/A 2026-02-07 |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
7,000 | $0 | 1,197,774 (Direct) |
View |
2022-12-29 Exercise |
2022-12-30 5:00 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
7,000 | $3.67 | 1,197,774 (Direct) |
View |
2022-04-25 Other |
2022-12-23 4:15 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Exec VP, Program Team Lead |
1,250 | $0 | 32,900 (Direct) |
View |
2022-12-22 Tax Withholding |
2022-12-23 4:15 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Exec VP, Program Team Lead |
89 | $51.68 | 32,900 (Direct) |
View |
2022-12-19 Exercise |
2022-12-21 4:13 pm |
N/A 2023-12-04 |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
49,888 | $0 | 2,494,191 (Direct) |
View |
2022-12-19 Exercise |
2022-12-21 4:13 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
28,200 | $2.67 | 2,494,191 (Direct) |
View |
2022-04-25 Other |
2022-12-21 4:13 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
12,500 | $0 | 2,494,191 (Direct) |
View |
2022-12-19 Exercise |
2022-12-21 4:13 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
15,000 | $3.76 | 2,494,191 (Direct) |
View |
2022-12-19 Exercise |
2022-12-21 4:13 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
6,688 | $14.95 | 2,494,191 (Direct) |
View |
2022-12-15 Exercise |
2022-12-19 4:37 pm |
N/A 2023-12-04 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $0 | 789,253 (Direct) |
View |
2022-12-15 Exercise |
2022-12-19 4:37 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $2.67 | 789,253 (Direct) |
View |
2022-12-08 Exercise |
2022-12-12 4:28 pm |
N/A 2023-12-05 |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
18,500 | $0 | 1,172,774 (Direct) |
View |
2022-12-08 Exercise |
2022-12-12 4:28 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
18,500 | $2.67 | 1,172,774 (Direct) |
View |
2022-12-05 Exercise |
2022-12-07 08:30 am |
N/A 2028-11-15 |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
5,000 | $0 | 350,407 (Direct) |
View |
2022-12-05 Exercise |
2022-12-07 08:30 am |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
5,000 | $15.09 | 350,407 (Direct) |
View |
2022-11-15 Exercise |
2022-11-17 4:33 pm |
N/A 2023-12-04 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $0 | 790,503 (Direct) |
View |
2022-11-15 Exercise |
2022-11-17 4:33 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $2.67 | 790,503 (Direct) |
View |
2022-11-08 Exercise |
2022-11-10 08:30 am |
N/A 2023-12-05 |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
18,500 | $0 | 1,184,774 (Direct) |
View |
2022-11-08 Exercise |
2022-11-10 08:30 am |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
18,500 | $2.67 | 1,184,774 (Direct) |
View |
2022-11-03 Exercise |
2022-11-07 4:19 pm |
N/A 2028-11-15 |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
5,000 | $0 | 355,407 (Direct) |
View |
2022-11-03 Exercise |
2022-11-07 4:19 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
5,000 | $15.09 | 355,407 (Direct) |
View |
2022-10-26 Tax Withholding |
2022-10-28 4:20 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Brown Victoria L. Program Team Lead |
130 | $58.41 | 24,844 (Direct) |
View |
2022-10-20 Tax Withholding |
2022-10-24 5:10 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
196 | $58 | 29,054 (Direct) |
View |
2022-10-20 Tax Withholding |
2022-10-24 5:09 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer |
130 | $58 | 18,451 (Direct) |
View |
2022-10-14 Exercise |
2022-10-17 5:57 pm |
N/A 2023-12-04 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $0 | 791,753 (Direct) |
View |
2022-10-14 Exercise |
2022-10-17 5:57 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $2.67 | 791,753 (Direct) |
View |
2022-10-10 Exercise |
2022-10-11 4:58 pm |
N/A 2023-12-05 |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
18,500 | $0 | 1,196,774 (Direct) |
View |
2022-10-10 Exercise |
2022-10-11 4:58 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
18,500 | $2.67 | 1,196,774 (Direct) |
View |
2022-10-03 Exercise |
2022-10-05 5:12 pm |
N/A 2028-11-15 |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
5,000 | $0 | 360,407 (Direct) |
View |
2022-10-03 Exercise |
2022-10-05 5:12 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
5,000 | $15.09 | 360,407 (Direct) |
View |
2022-09-15 Exercise |
2022-09-16 4:03 pm |
N/A 2023-12-04 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $0 | 793,003 (Direct) |
View |
2022-09-15 Exercise |
2022-09-16 4:03 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $2.67 | 793,003 (Direct) |
View |
2022-09-08 Exercise |
2022-09-12 4:52 pm |
N/A 2023-12-05 |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
18,500 | $0 | 1,208,774 (Direct) |
View |
2022-09-08 Exercise |
2022-09-12 4:52 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
18,500 | $2.67 | 1,208,774 (Direct) |
View |
2022-09-06 Exercise |
2022-09-07 4:37 pm |
N/A 2028-11-15 |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
5,000 | $0 | 365,407 (Direct) |
View |
2022-09-06 Exercise |
2022-09-07 4:37 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
5,000 | $15.09 | 365,407 (Direct) |
View |